TSSK 4 activators encompass a diverse range of chemical entities that function through various biochemical mechanisms to increase the activity of this particular protein. For instance, some compounds achieve activation by modulating the intracellular levels of second messengers like cAMP and cGMP, thereby influencing signaling pathways that are instrumental in TSSK 4 regulation. These activators typically function by either directly stimulating the production of these cyclic nucleotides via activation of adenylate cyclase or by preventing their breakdown through inhibition of phosphodiesterases, thus prolonging their signaling effect. Such sustained levels of cyclic nucleotides could prime pathways that upregulate TSSK 4 activity. Moreover, certain activators work by altering the phosphorylation state of proteins within the cell. This is achieved by inhibiting protein phosphatases, leading to an accumulation of phosphorylated proteins that, in turn, might engage signaling cascades associated with TSSK 4 activation, thus potentially escalating its functional activity within the cell.
Further contributing to the activation of TSSK 4 are compounds that impact calcium signaling. This is executed through the use of calcium ionophores, which increase the intracellular calcium concentration, and could thereby modulate TSSK 4 as it is postulated to be responsive to calcium-dependent signals. Additionally, activators that target protein kinase C (PKC) induce a series of events that are known to culminate in the activation of numerous proteins, which may include TSSK 4 as part of the broader PKC-mediated signaling response. Other mechanisms involve the response to cellular stress, where activators that induce stress-activated protein kinase pathways are implicated in modulating the activity of TSSK 4.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Activates adenylate cyclase and increases cAMP levels, which could enhance TSSK 4 activity in processes that are regulated by cyclic nucleotide signaling. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $159.00 $315.00 $598.00 | 34 | |
Non-specific inhibitor of phosphodiesterases, thus leading to an increase in cAMP and cGMP which may indirectly enhance TSSK 4 activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Calcium ionophore that increases intracellular calcium concentration, potentially modulating TSSK 4 activity as calcium signaling may regulate its function. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
Activator of protein kinase C (PKC) which could activate TSSK 4 through downstream PKC-mediated signaling pathways. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $54.00 $128.00 $199.00 $311.00 | 23 | |
Calcium ionophore, potentially influencing TSSK 4 activity by altering calcium-dependent signaling mechanisms. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $285.00 $520.00 $1300.00 | 78 | |
Inhibitor of protein phosphatases PP1 and PP2A, leading to increased phosphorylation levels that could contribute to TSSK 4 activation. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A sc-24000B sc-24000C | 10 µg 100 µg 500 µg 1 mg | $160.00 $750.00 $1400.00 $3000.00 | 59 | |
Inhibitor of protein phosphatases PP1 and PP2A like Okadaic acid, potentially enhancing the phosphorylation state that promotes TSSK 4 activity. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $45.00 $130.00 $480.00 $4450.00 | 74 | |
Cell-permeable cAMP analog that can mimic the effect of endogenous cAMP, possibly facilitating TSSK 4 activation via cAMP-dependent pathways. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $103.00 $245.00 | 8 | |
Selective inhibitor of phosphodiesterase 5 (PDE5), increasing cGMP levels which may indirectly result in enhanced TSSK 4 activity. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $97.00 $254.00 | 36 | |
Activates stress-activated protein kinases, which may influence TSSK 4 activity through stress response signaling pathways. | ||||||